Confluence Investment Management LLC Sells 77,227 Shares of The Clorox Company $CLX

Confluence Investment Management LLC lessened its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 6.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 1,170,417 shares of the company’s stock after selling 77,227 shares during the period. Clorox comprises approximately 1.4% of Confluence Investment Management LLC’s investment portfolio, making the stock its 22nd biggest position. Confluence Investment Management LLC’s holdings in Clorox were worth $94,815,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Envestnet Portfolio Solutions Inc. increased its position in Clorox by 106.9% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 4,375 shares of the company’s stock worth $418,000 after buying an additional 2,260 shares during the last quarter. Andra AP fonden acquired a new stake in shares of Clorox in the second quarter worth about $200,000. MAC Alpha Capital Management LP lifted its position in shares of Clorox by 88.7% in the second quarter. MAC Alpha Capital Management LP now owns 263,789 shares of the company’s stock worth $25,178,000 after buying an additional 124,019 shares during the last quarter. Security National Bank of SO Dak bought a new stake in shares of Clorox during the 2nd quarter worth about $57,000. Finally, Anchor Investment Management LLC increased its holdings in shares of Clorox by 13.0% during the 2nd quarter. Anchor Investment Management LLC now owns 14,719 shares of the company’s stock valued at $1,405,000 after acquiring an additional 1,699 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of CLX traded down $0.75 during trading hours on Thursday, reaching $80.26. 1,556,292 shares of the company traded hands, compared to its average volume of 2,652,154. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The stock’s fifty day moving average is $96.20 and its 200 day moving average is $97.16. The Clorox Company has a 1-year low of $79.12 and a 1-year high of $128.90. The stock has a market cap of $9.71 billion, a P/E ratio of 16.65, a price-to-earnings-growth ratio of 2.55 and a beta of 0.56.

Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. During the same period last year, the business earned $2.87 earnings per share. The firm’s revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Equities research analysts anticipate that The Clorox Company will post 5.8 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 6.2%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox’s dividend payout ratio (DPR) is presently 103.73%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft set a $98.00 target price on Clorox in a report on Tuesday, August 4th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $92.00 to $95.00 and gave the stock an “underweight” rating in a report on Tuesday, August 4th. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, September 19th. Barclays restated an “underweight” rating and set a $84.00 price target on shares of Clorox in a report on Tuesday, August 4th. Finally, UBS Group reiterated a “neutral” rating on shares of Clorox in a research note on Friday, September 11th. Thirteen analysts have rated the stock with a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, Clorox has an average rating of “Reduce” and an average target price of $101.40.

Get Our Latest Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company is a consumer and professional products company that develops, manufactures and markets household cleaning, disinfecting, wellness and personal care products. Its portfolio includes the Clorox bleach and cleaning brands, as well as products sold under brands such as Pine-Sol, Liquid-Plumr, Fresh Step, Scoop Away, Kingsford, Hidden Valley, Burt’s Bees and Brita.

Clorox also offers trash bags, food products, water-filtration systems, charcoal and grilling products, cat litter, and professional cleaning and disinfecting solutions.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.